BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chang SC, Goh KK, Lu ML. Metabolic disturbances associated with antipsychotic drug treatment in patients with schizophrenia: State-of-the-art and future perspectives. World J Psychiatr 2021; 11(10): 696-710 [PMID: 34733637 DOI: 10.5498/wjp.v11.i10.696]
URL: https://www.wjgnet.com/1007-9327/full/v11/i10/696.htm
Number Citing Articles
1
Katerina Horska, Silje Skrede, Jan Kucera, Gabriela Kuzminova, Pavel Suchy, Vincenzo Micale, Jana Ruda‐Kucerova. Olanzapine, but not haloperidol, exerts pronounced acute metabolic effects in the methylazoxymethanol rat modelCNS Neuroscience & Therapeutics 2024; 30(2) doi: 10.1111/cns.14565
2
Giuseppe Forte, Francesca Favieri, Mariella Pazzaglia, Maria Casagrande. Mental and Body Health: The Association between Psychological Factors, Overweight, and Blood Pressure in Young AdultsJournal of Clinical Medicine 2022; 11(7): 1999 doi: 10.3390/jcm11071999
3
Shokouh Arjmand, Caroline Biojone, Gregers Wegener. Modulation of Leucine Sensors to Mitigate Antipsychotics-Induced Metabolic Syndrome: A New VistaACS Pharmacology & Translational Science 2024; 7(1): 294 doi: 10.1021/acsptsci.3c00319
4
Marco Carli, Francesco Weiss, Giovanna Grenno, Sergio Ponzini, Shivakumar Kolachalam, Francesca Vaglini, Cristina Viaggi, Carla Pardini, Simone Tidona, Biancamaria Longoni, Roberto Maggio, Marco Scarselli. Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical AntipsychoticsCurrent Neuropharmacology 2023; 21(4): 935 doi: 10.2174/1570159X21666230224102318
5
Wei Zhou, Jing Sun, Cong Huai, Yunxi Liu, Luan Chen, Zhenghui Yi, Qinyu Lv, Chuanfu Song, Wenli Zhu, Chuanxin Liu, Saizheng Weng, Hao Wu, Yidan Sun, Runshuai Zhang, Lianfeng Wu, Mo Li, Jinhang Zhu, Yingtian Zhang, Muyun Wei, Yujian Guo, Sijia Huang, Na Zhang, Ruoxi Shen, Ying Zhang, Huihui Du, Hailiang Huang, Lin He, Xiaofang Sun, Lu Shen, Shengying Qin. Multi-omics analysis identifies rare variation in leptin/PPAR gene sets and hypermethylation of ABCG1 contribute to antipsychotics-induced metabolic syndromesMolecular Psychiatry 2022; 27(12): 5195 doi: 10.1038/s41380-022-01759-5
6
E. G. Kornetova, A. A. Goncharova, I. A. Mednova, A. N. Kornetov, T. V. Saprina, O. E. Perchatkina, A. V. Semke. Somatotype and morphological characteristics of metabolic syndrome in patients with schizophrenia and persons without mental disordersBulletin of Siberian Medicine 2023; 22(1): 57 doi: 10.20538/1682-0363-2023-1-57-64
7
Nicolette Stogios, Bailey Humber, Sri Mahavir Agarwal, Margaret Hahn. Antipsychotic-Induced Weight Gain in Severe Mental Illness: Risk Factors and Special ConsiderationsCurrent Psychiatry Reports 2023; 25(11): 707 doi: 10.1007/s11920-023-01458-0
8
Pelumi Samuel Akinola, Isabelle Tardif, Jacinthe Leclerc. Antipsychotic-Induced Metabolic Syndrome: A ReviewMetabolic Syndrome and Related Disorders 2023; 21(6): 294 doi: 10.1089/met.2023.0003
9
Kah Kheng Goh, Cynthia Yi-An Chen, Tzu-Hua Wu, Chun-Hsin Chen, Mong-Liang Lu. Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic DysfunctionInternational Journal of Molecular Sciences 2022; 23(13): 7092 doi: 10.3390/ijms23137092
10
Zhiyong Gao, Meihong Xiu, Jiahong Liu, Fengchun Wu, Xiang-Yang Zhang. Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidoneSchizophrenia 2023; 9(1) doi: 10.1038/s41537-023-00346-z
11
Nousayhah Amdanee, Miaomiao Shao, Xiuxiu Hu, Xinyu Fang, Chao Zhou, Jiu Chen, Mohammad Ridwan Chattun, Lu Wen, Xinming Pan, Xiangrong Zhang, Yue Xu. Serum Metabolic Profile in Schizophrenia Patients With Antipsychotic-Induced Constipation and Its relationship With Gut MicrobiomeSchizophrenia Bulletin 2023; 49(3): 646 doi: 10.1093/schbul/sbac202
12
Katja Häkkinen, Wilma Kiander, Heidi Kidron, Markku Lähteenvuo, Lea Urpa, Jonne Lintunen, Kati-Sisko Vellonen, Seppo Auriola, Minna Holm, Kaisla Lahdensuo, Olli Kampman, Erkki Isometsä, Tuula Kieseppä, Jouko Lönnqvist, Jaana Suvisaari, Jarmo Hietala, Jari Tiihonen, Aarno Palotie, Ari V. Ahola-Olli, Mikko Niemi. Functional Characterization of Six SLCO1B1 (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic DisorderMolecular Pharmaceutics 2023; 20(3): 1500 doi: 10.1021/acs.molpharmaceut.2c00715
13
Chao Yang, Xiaoxiao Lin, Xianteng Wang, Huanzhong Liu, Jinyu Huang, Shuai Wang. The schizophrenia and gut microbiota: A bibliometric and visual analysisFrontiers in Psychiatry 2022; 13 doi: 10.3389/fpsyt.2022.1022472
14
Jose M. Rubio, John M. Kane. The pharmacological treatment of schizophrenia: How far have we come?Psychiatry and Clinical Neurosciences Reports 2022; 1(2) doi: 10.1002/pcn5.13
15
Eva-Maria Tsapakis, Konstantinos N. Fountoulakis, Stefania Kanioura, Haim Einat. Significant contribution of chronotype to emotional well-being in chronic psychiatric outpatients in GreeceNeuroscience Applied 2024; 3: 103940 doi: 10.1016/j.nsa.2024.103940
16
Kuan Zeng, Shuo Wang, Lin Zhang, Yanting Zhang, Jun Ma. Gender differences in prevalence and associated factors of metabolic syndrome in first-treatment and drug-naïve schizophrenia patientsAnnals of General Psychiatry 2023; 22(1) doi: 10.1186/s12991-023-00455-0
17
Zhongzi Ma, Zhongnv Ma. Relationship between stable smoking behavior and cognitive function in male schizophrenia patientsJournal of Psychiatric Research 2024; 173: 296 doi: 10.1016/j.jpsychires.2024.03.034